About: Evaluating efficiency of pooling specimens for PCR-based detection of COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Evaluating efficiency of pooling specimens for PCR-based detection of COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Evaluating efficiency of pooling specimens for PCR-based detection of COVID-19
Creator	Buathong, Rome Ghai, Siriporn Hemachudha, Thiravat Kaewpom, Thongchai Plipat, Tanarak Wacharapluesadee, Supaporn Ampoot, Weenassarin Hemachudha, Pasin Jantarabenjakul, Watsamon Khamhang, Worrawat Krichphiphat, Artit Nopvichai, Chatchai Paitoonpong, Leilani Putcharoen, Opass Supharatpariyakorn, Thirawat Suwanpimolkul, Gompol Wanthong, Phanni Worachotsueptrakun, Kanthita
Source	MedRxiv
abstract	In the age of a pandemic, such as the ongoing one caused by SARS-CoV-2, the world faces limited supply of tests, PPE and reagents, and factories are struggling to meet the growing demands. This study aimed to evaluate the efficacy of pooling specimen for testing of SARS-CoV-2 virus, to determine whether costs and resource savings could be achieved without impacting the sensitivity of the testing. Ten specimens were pooled for testing, containing either one or two known positive specimen of varying viral concentrations. Pooling specimens did not affect the sensitivity of detecting SARS-CoV-2, and the PCR cycle threshold (Ct) between testing of pooling specimen and subsequent individual testing was not significantly different using paired t-test. This study also identified cost savings garnered from pooling of specimen for testing at 4 differing prevalence rates, ranging from 0.1-10%. Pooling specimens to test for COVID-19 infection in low prevalence areas or in low risk population can dramatically decrease the resources burden on lab operations by up to 80%. This paves the possibility for large-scale population screening, allowing for assured policy decisions by governmental bodies to ease lockdown restrictions in areas with low incidence of infection, or with lower risk populations.
has issue date	2020-05-06(xsd:dateTime)
bibo:doi	10.1101/2020.05.02.20087221
has license	medrxiv
sha1sum (hex)	5ffe9a1602b9c0959380eb15dfb78906ced112b4
schema:url	https://doi.org/10.1101/2020.05.02.20087221
resource representing a document's title	Evaluating efficiency of pooling specimens for PCR-based detection of COVID-19
resource representing a document's body	covid:5ffe9a1602b9c0959380eb15dfb78906ced112b4#body_text
is schema:about of	named entity 'study' named entity 't-test' named entity 'LIMITED' covid:arg/5ffe9a1602b9c0959380eb15dfb78906ced112b4 named entity 'paired' named entity 'caused' named entity 'growing' named entity 'tests' named entity 'viral' named entity 'sensitivity' named entity 'SARS-CoV-2' named entity 'PPE' named entity 'Cost-effectiveness' named entity 'infection' named entity 'PCR' named entity 'patient specimens' named entity 'infection rate' named entity 'qPCR' named entity 'paired t-test' named entity 'PCR' named entity 'preprint' named entity 'COVID' named entity 'medRxiv' named entity 'preprint' named entity 'disease prevalence' named entity 'preprint' named entity 'nasopharyngeal' named entity 'asymptomatic' named entity 'RNA' named entity 'real-time PCR' named entity 'exit strategy' named entity 'SARS-CoV-2' named entity 'preprint' named entity 'preprint' named entity 'preprint' named entity 'medRxiv' named entity 'viral RNA' named entity 'May 6' named entity 'qPCR' named entity '1,000,000' named entity 'COVID' named entity 'CC-BY-NC-ND 4.0' named entity 'Real-time PCR' named entity 'United States' named entity 'qPCR' named entity 'RNA extraction' named entity 'real-time polymerase chain reaction' named entity 'COVID-19 pandemic' named entity 'medRxiv' named entity 'medRxiv' named entity 'bioMérieux' named entity 'DNA and RNA' named entity 'medRxiv' named entity 'BGI' named entity 'France' named entity 'SARS-CoV-2' named entity 'medRxiv' named entity 'VTM' named entity 'May 6' named entity 'preprint' named entity 'preprint' named entity 'preprint' named entity 'medRxiv' named entity 'COVID' named entity 'copyright holder' named entity 'copyright holder' named entity 'SARS-CoV-2 virus' named entity 'SARS-CoV-2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software